KCNH3

KCNH3 (Kv12.2) is a subthreshold-activating, voltage-gated K+ channel of the Elk subfamily that sets neuronal excitability in the CNS (PMID:19923296, PMID:37516908). It assembles into channels that can heteromultimerize selectively with other Elk-family subunits (KCNH8, KCNH4) but not with Eag, Erg, or Kv channels (PMID:12890647), and its surface delivery and gating depend on N-glycosylation of three sites in the S5-P loop, loss of which causes a depolarizing activation shift and trafficking failure in heterologous cells and in brain (PMID:19808681). At the plasma membrane its current is restrained by auxiliary KCNE1 and KCNE3 beta-subunits, which co-assemble simultaneously with the channel as a tripartite complex that limits surface expression and shifts activation voltage; knockdown of these subunits markedly increases macroscopic current (PMID:19623261). Channel gating is further tuned by external protons acting through a pair of EAG-specific acidic voltage-sensor residues that shift the conductance-voltage relationship (PMID:23712551). Physiologically, Kv12.2 generates the day-night switch in spontaneous firing of suprachiasmatic nucleus neurons by suppressing nighttime firing (PMID:37516908), and it bidirectionally controls cognition: knockout enhances while forebrain overexpression impairs working memory, reference memory, and attention, with corresponding changes in hippocampal excitability and synaptic plasticity (PMID:19923296). A heterozygous de novo p.Ala371Val variant causes dominant-negative loss-of-function and is linked to a neurodevelopmental disorder (PMID:40157307).

1. 2003 Medium

   Established the subunit assembly rules for KCNH3, answering whether it forms homomeric or heteromeric channels and with which partners.

   Evidence Dominant-negative co-expression and electrophysiology in Xenopus oocytes

   PMID:12890647

   Open questions at the time

   • Stoichiometry and structure of Elk-family heteromers not resolved
   • Functional consequence of heteromerization for native channel properties not determined
   • No reciprocal validation outside the oocyte system
2. 2009 High

   Identified KCNE1 and KCNE3 as native auxiliary beta-subunits forming a tripartite complex that controls Kv12.2 surface expression and activation voltage, defining how the channel is regulated at the membrane.

   Evidence siRNA knockdown, overexpression, oocyte electrophysiology, surface biotinylation, and native co-IP from mouse brain

   PMID:19623261

   Open questions at the time

   • Stoichiometry of the KCNE1-KCNE3-Kv12.2 complex unknown
   • Structural basis of KCNE-mediated suppression not defined
3. 2009 High

   Showed that N-glycosylation of the S5-P loop is required for Kv12.2 surface trafficking and normal gating, explaining a post-translational determinant of channel availability.

   Evidence Site-directed mutagenesis, electrophysiology, and trafficking assays in CHO cells, neurons, and mouse brain

   PMID:19808681

   Open questions at the time

   • Glycan-binding chaperones or trafficking machinery not identified
   • Mechanistic link between glycosylation and activation shift unresolved
4. 2009 High

   Demonstrated a bidirectional role for KCNH3 in cognition, answering whether channel dose tunes learning and memory through neuronal excitability.

   Evidence Knockout and forebrain-overexpression mice with behavioral tasks and hippocampal electrophysiology

   PMID:19923296

   Open questions at the time

   • Circuit-level mechanism linking excitability changes to specific cognitive tasks not defined
   • Cell types responsible for the behavioral phenotype not pinpointed
5. 2013 High

   Localized proton sensitivity to EAG-specific acidic voltage-sensor residues, revealing how external pH tunes low-threshold activation.

   Evidence Voltage-clamp conductance-voltage analysis at varying pH with site-directed mutagenesis across EAG superfamily members

   PMID:23712551

   Open questions at the time

   • Whether residues directly bind protons or maintain a pH-sensitive conformation not distinguished
   • Physiological pH ranges affecting native Kv12.2 not established
6. 2016 Low

   Placed Kcnh3 downstream of the transcription factor FOXG1 in neurons, addressing how channel expression is controlled developmentally.

   Evidence FOXG1 target gene identification during telencephalic development

   PMID:27224923

   Open questions at the time

   • Single-lab transcriptional association without detailed mechanistic follow-up
   • Direct promoter binding and regulatory element not mapped
7. 2019 Medium

   Showed that selective pharmacological block of Kv12.2 produces antipsychotic-like and pro-cognitive effects, validating the channel as a behavioral target.

   Evidence Selective inhibitor ASP2905 in mouse hyperlocomotion, forced-swim, and latent-learning paradigms

   PMID:31654662

   Open questions at the time

   • On-target specificity in vivo not fully excluded
   • Cellular/circuit site of drug action not identified
8. 2021 Low

   Mapped Kv12.2 expression to NTS Phox2b neurons, raising the possibility of a role in central respiratory chemoreception.

   Evidence Immunofluorescence, Western blot, and RT-PCR in mouse NTS

   PMID:33903883

   Open questions at the time

   • No functional consequence of NTS expression demonstrated
   • Contribution to chemoreceptor pH sensing untested
9. 2023 High

   Defined a physiological function for Kv12.2 in driving the day-night switch in SCN neuron firing, connecting subthreshold K+ conductance to circadian electrical output.

   Evidence Knockout and shRNA mice, SCN slice current/voltage-clamp, pharmacology, and dynamic clamp

   PMID:37516908

   Open questions at the time

   • Mechanism coupling clock state to time-of-day current-density changes unknown
   • Whether KCNE regulation or glycosylation underlies diurnal current changes not tested
10. 2025 Medium

    Established a disease mechanism by showing a de novo missense variant causes dominant-negative loss-of-function, linking KCNH3 to a neurodevelopmental disorder.

    Evidence Voltage-clamp of WT and mutant KCNH3 with WT/mutant co-expression in Xenopus oocytes

    PMID:40157307

    Open questions at the time

    • Single in vitro study without patient-derived neuronal validation
    • Phenotypic spectrum and genotype-phenotype correlation not established

• How channel regulation (KCNE complex assembly, glycosylation, proton sensitivity) is integrated to produce time-of-day and circuit-specific firing control, and how loss-of-function variants translate to human neurodevelopmental phenotypes, remains unresolved.
• No structural model of the regulated channel complex
• Causal link between molecular regulation and circadian current changes unknown
• Human disease mechanism not validated in native neurons